Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
$12.52
-1.8%
$9.90
$6.27
$21.44
$372.72M2.241.17 million shs1.91 million shs
Allient Inc. stock logo
ALNT
Allient
$35.92
-0.5%
$29.58
$16.91
$36.63
$608.13M1.47114,822 shs172,791 shs
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$9.64
-7.0%
$7.34
$3.91
$17.00
$663.33M1.61813,280 shs1.83 million shs
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
$0.69
-14.0%
$0.74
$0.66
$3.09
$87.51M1.44155,512 shs5.72 million shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
0.00%+12.29%+31.37%+71.74%+12.09%
Allient Inc. stock logo
ALNT
Allient
0.00%+6.52%+16.59%+63.42%+42.14%
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
0.00%+14.49%+33.70%+77.86%+10.80%
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
0.00%-2.94%-6.90%-19.43%-70.35%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
4.0217 of 5 stars
3.53.00.00.02.02.53.1
Allient Inc. stock logo
ALNT
Allient
2.5089 of 5 stars
1.33.01.70.03.42.51.9
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
2.3809 of 5 stars
3.53.00.00.02.51.70.0
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
2.4549 of 5 stars
2.52.00.00.03.04.20.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
3.00
Buy$25.0099.68% Upside
Allient Inc. stock logo
ALNT
Allient
2.50
Moderate Buy$31.00-13.70% Downside
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
3.00
Buy$25.67166.25% Upside
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
1.00
Sell$2.13206.33% Upside

Current Analyst Ratings Breakdown

Latest NAUT, EYPT, ALNT, and AEHR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/17/2025
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$28.00
5/29/2025
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$22.00
5/16/2025
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$30.00 ➝ $26.00
5/8/2025
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
Chardan Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$33.00 ➝ $27.00
5/5/2025
Allient Inc. stock logo
ALNT
Allient
Northland Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$35.00
5/5/2025
Allient Inc. stock logo
ALNT
Allient
Northland Capmk
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
5/5/2025
Allient Inc. stock logo
ALNT
Allient
Northland Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform
(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
$66.22M5.63$1.20 per share10.45$3.86 per share3.24
Allient Inc. stock logo
ALNT
Allient
$529.97M1.15$3.03 per share11.84$15.72 per share2.28
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$43.27M15.33N/AN/A$4.93 per share1.96
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
N/AN/AN/AN/A$1.66 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
$33.16M$0.7816.0556.91N/A37.17%21.15%18.13%7/15/2025 (Estimated)
Allient Inc. stock logo
ALNT
Allient
$13.17M$0.5960.8819.63N/A1.90%8.45%3.86%8/6/2025 (Estimated)
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
-$130.87M-$2.41N/AN/AN/A-261.91%-54.27%-41.75%8/6/2025 (Estimated)
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
-$70.78M-$0.54N/AN/AN/AN/A-31.87%-27.39%7/29/2025 (Estimated)

Latest NAUT, EYPT, ALNT, and AEHR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/15/2025Q4 2025
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
-$0.0150N/AN/AN/A$14.83 millionN/A
5/7/2025Q1 2025
Allient Inc. stock logo
ALNT
Allient
$0.33$0.46+$0.13$0.21$125.00 million$134.62 million
5/7/2025Q1 2025
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
-$0.65-$0.65N/A-$0.65$8.84 million$24.50 million
4/29/2025Q1 2025
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
-$0.14-$0.13+$0.01-$0.13N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
N/AN/AN/AN/AN/A
Allient Inc. stock logo
ALNT
Allient
$0.120.33%N/A20.34%N/A
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
N/AN/AN/AN/AN/A
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
N/AN/AN/AN/AN/A

Latest NAUT, EYPT, ALNT, and AEHR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/7/2025
Allient Inc. stock logo
ALNT
Allient
quarterly$0.030.4%5/22/20255/22/20256/5/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
N/A
5.71
3.07
Allient Inc. stock logo
ALNT
Allient
0.81
4.03
2.35
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
N/A
7.85
7.79
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
N/A
17.36
17.36

Institutional Ownership

CompanyInstitutional Ownership
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
69.69%
Allient Inc. stock logo
ALNT
Allient
61.57%
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
99.41%
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
50.71%

Insider Ownership

CompanyInsider Ownership
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
6.20%
Allient Inc. stock logo
ALNT
Allient
14.90%
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
4.46%
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
41.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
9029.77 million27.93 millionOptionable
Allient Inc. stock logo
ALNT
Allient
2,52516.93 million14.41 millionOptionable
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
12068.81 million65.74 millionOptionable
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
130126.15 million74.30 millionOptionable

Recent News About These Companies

Nautilus Biotechnology Leads The Pack In Our Top 3 Penny Stocks
Q1 2025 Nautilus Biotechnology Inc Earnings Call
Nautilus Biotechnology price target lowered to $2.50 from $4 at Guggenheim

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Aehr Test Systems stock logo

Aehr Test Systems NASDAQ:AEHR

$12.52 -0.23 (-1.80%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$12.86 +0.35 (+2.76%)
As of 05:54 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices. The company also offers FOX-CP system, a low-cost single-wafer compact test solution for logic, memory, and photonic devices; FOX WaferPak Contactor, a full wafer contactor capable of testing wafers up to 300mm that enables integrated circuit manufacturers to perform test, burn-in, and stabilization of full wafers on the FOX-P systems. In addition, it provides FOX DiePak Carrier, a reusable temporary package that enables IC manufacturers to perform final test and burn-in of bare die and modules; and FOX DiePak Loader. The company was incorporated in 1977 and is headquartered in Fremont, California.

Allient stock logo

Allient NASDAQ:ALNT

$35.92 -0.18 (-0.50%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$35.92 0.00 (0.00%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Allient Inc., together with its subsidiaries, designs, manufactures, and sells precision and specialty controlled motion components and systems for various industries in the United States, Canada, South America, Europe, and Asia-Pacific. It offers brush and brushless DC motors, brushless servo and torque motors, coreless DC motors, integrated brushless motor-drives, gearmotors, gearing, modular digital servo drives, motion controllers, optical encoders, active and passive filters, input/output modules, industrial communications gateways, light-weighting technologies, and other controlled motion-related products, as well as nano precision positioning systems, servo control systems, and digital servo amplifiers and drives. The company sells its products to end customers and original equipment manufacturers in vehicle, medical, aerospace and defense, and industrial markets through direct sales force, authorized manufacturers' representatives, and distributors. The company was formerly known as Allied Motion Technologies Inc. and changed its name to Allient Inc. in August 2023. Allient Inc. was incorporated in 1962 and is headquartered in Amherst, New York.

Eyepoint Pharmaceuticals stock logo

Eyepoint Pharmaceuticals NASDAQ:EYPT

$9.64 -0.73 (-7.04%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$17.00 +7.36 (+76.35%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

EyePoint Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is EYP-1901, an investigational sustained delivery treatment for VEGF-mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 2 clinical trials for wet age-related macular degeneration (wet AMD), non-proliferative diabetic retinopathy (NPDR), and diabetic macular edema (DME). The company's pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E to potentially improve outcomes in serious retinal diseases. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018. EyePoint Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts.

Nautilus Biotechnology stock logo

Nautilus Biotechnology NASDAQ:NAUT

$0.69 -0.11 (-14.04%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$0.78 +0.08 (+12.01%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.